Literature DB >> 28222515

Meta-Analysis of Parkinson's Disease and Alzheimer's Disease Revealed Commonly Impaired Pathways and Dysregulation of NRF2-Dependent Genes.

Qian Wang1,2, Wen-Xing Li1,3, Shao-Xing Dai1,2, Yi-Cheng Guo1, Fei-Fei Han4, Jun-Juan Zheng1,2, Gong-Hua Li1,2, Jing-Fei Huang1,2,5,6,7.   

Abstract

Many lines of evidence suggest that Parkinson's disease (PD) and Alzheimer's disease (AD) have common characteristics, such as mitochondrial dysfunction and oxidative stress. As the underlying molecular mechanisms are unclear, we perform a meta-analysis with 9 microarray datasets of PD studies and 7 of AD studies to explore it. Functional enrichment analysis revealed that PD and AD both showed dysfunction in the synaptic vesicle cycle, GABAergic synapses, phagosomes, oxidative phosphorylation, and TCA cycle pathways, and AD had more enriched genes. Comparing the differentially expressed genes between AD and PD, we identified 54 common genes shared by more than six tissues. Among them, 31 downregulated genes contained the antioxidant response element (ARE) consensus sequence bound by NRF2. NRF2 is a transcription factor, which protects cells against oxidative stress through coordinated upregulation of ARE-driven genes. To our surprise, although NRF2 was upregulated, its target genes were all downregulated. Further exploration found that MAFF was upregulated in all tissues and significantly negatively correlated with the 31 NRF2-dependent genes in diseased conditions. Previous studies have demonstrated over-expressed small MAFs can form homodimers and act as transcriptional repressors. Therefore, MAFF might play an important role in dysfunction of NRF2 regulatory network in PD and AD.

Entities:  

Keywords:  Alzheimer’s disease; MAFF; NRF2; Parkinson’s disease; meta-analysis

Mesh:

Substances:

Year:  2017        PMID: 28222515     DOI: 10.3233/JAD-161032

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  30 in total

Review 1.  Crosstalk between Nrf2 signaling and mitochondrial function in Parkinson's disease.

Authors:  Navneet Ammal Kaidery; Manuj Ahuja; Bobby Thomas
Journal:  Mol Cell Neurosci       Date:  2019-10-20       Impact factor: 4.314

Review 2.  Nrf2/ARE Pathway as a Therapeutic Target for the Treatment of Parkinson Diseases.

Authors:  Artem P Gureev; Vasily N Popov
Journal:  Neurochem Res       Date:  2019-01-07       Impact factor: 3.996

Review 3.  The Relationships Among Metal Homeostasis, Mitochondria, and Locus Coeruleus in Psychiatric and Neurodegenerative Disorders: Potential Pathogenetic Mechanism and Therapeutic Implications.

Authors:  Yutaka Nakagawa; Shizuo Yamada
Journal:  Cell Mol Neurobiol       Date:  2022-05-30       Impact factor: 5.046

Review 4.  The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders.

Authors:  Margrethe A Olesen; Francisca Villavicencio-Tejo; Rodrigo A Quintanilla
Journal:  Transl Neurodegener       Date:  2022-07-04       Impact factor: 9.883

5.  Establishment and Analysis of a Combined Diagnostic Model of Alzheimer's Disease With Random Forest and Artificial Neural Network.

Authors:  Dazhong Sun; Haojun Peng; Zhibing Wu
Journal:  Front Aging Neurosci       Date:  2022-06-30       Impact factor: 5.702

Review 6.  Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice-Which to Use Regarding Disease Outcomes?

Authors:  Alain Menzel; Hanen Samouda; Francois Dohet; Suva Loap; Mohammed S Ellulu; Torsten Bohn
Journal:  Antioxidants (Basel)       Date:  2021-03-09

7.  Deletion of Nrf2 shortens lifespan in C57BL6/J male mice but does not alter the health and survival benefits of caloric restriction.

Authors:  Laura C D Pomatto; Theresa Dill; Bethany Carboneau; Sophia Levan; Jonathan Kato; Evi M Mercken; Kevin J Pearson; Michel Bernier; Rafael de Cabo
Journal:  Free Radic Biol Med       Date:  2020-01-15       Impact factor: 7.376

Review 8.  Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities.

Authors:  Juan I Sbodio; Solomon H Snyder; Bindu D Paul
Journal:  Antioxid Redox Signal       Date:  2018-05-04       Impact factor: 8.401

Review 9.  Mechanistic interplay of various mediators involved in mediating the neuroprotective effect of daphnetin.

Authors:  Lovedeep Singh; Amrit Pal Singh; Rajbir Bhatti
Journal:  Pharmacol Rep       Date:  2021-04-16       Impact factor: 3.024

10.  The key genes, phosphoproteins, processes, and pathways affected by efavirenz-activated CYP46A1 in the amyloid-decreasing paradigm of efavirenz treatment.

Authors:  Alexey M Petrov; Natalia Mast; Yong Li; Irina A Pikuleva
Journal:  FASEB J       Date:  2019-05-07       Impact factor: 5.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.